Role of chemokines in severe asthma - PubMed (original) (raw)
Review
Role of chemokines in severe asthma
L A Murray et al. Curr Drug Targets. 2006 May.
Abstract
The severe asthma phenotype is exhibited by a subset of asthma patients whose asthma symptom is poorly controlled by current therapies. Severe asthma represents a high unmet medical need and warrants research into the mechanisms driving the underlying pathophysiology. It is hypothesized that the underlying pathology associated with severe asthma is driving the symptoms experienced by these patients, which may share common features with mild to moderate asthma or may represent a unique pathological phenotype. For the purpose of this review, the pathophysiology associated with asthma in general are described and extended to incorporate severe asthma. Chemokines may contribute towards multiple features of asthma pathophysiology and this current review focuses on the biology of chemokines pertaining to asthma pathophysiology. Chemokines are important recruiters and activators of inflammatory cells and these infiltrating cells interact with resident cells, such as fibroblasts and it is through these pathways that chemokines appear to exert multiple biological actions. Clinical trials are underway with therapeutics targeting chemokine pathways for other inflammatory diseases. It is hoped that the information generated from these studies will contribute towards furthering our understanding of chemokine biology and be applied towards targeting severe asthma.
Similar articles
- The pathology of chronic asthma.
Muro S, Minshall EM, Hamid QA. Muro S, et al. Clin Chest Med. 2000 Jun;21(2):225-44. doi: 10.1016/s0272-5231(05)70263-x. Clin Chest Med. 2000. PMID: 10907585 Review. - [Molecular medicine in asthma].
Ohta K. Ohta K. Nihon Rinsho. 2005 May;63 Suppl 5:63-7. Nihon Rinsho. 2005. PMID: 15954326 Review. Japanese. No abstract available. - [Cytokines and asthma].
Rekik WK, Ayoub A. Rekik WK, et al. Tunis Med. 1998 Feb;76(2):1027-32. Tunis Med. 1998. PMID: 9844537 Review. French. No abstract available. - The laws of attraction: chemokines, neutrophils and eosinophils in severe exacerbations of asthma.
Turato G, Baraldo S, Zuin R, Saetta M. Turato G, et al. Thorax. 2007 Jun;62(6):465-6. doi: 10.1136/thx.2006.070656. Thorax. 2007. PMID: 17536024 Free PMC article. - [Inflammatory aspects in bronchial asthma].
Sato A, Hayakawa H, Iwata M, Taniguchi M. Sato A, et al. Kokyu To Junkan. 1991 Sep;39(9):845-9. Kokyu To Junkan. 1991. PMID: 1749861 Japanese. No abstract available.
Cited by
- Chemokines and their receptors in the allergic airway inflammatory process.
Velazquez JR, Teran LM. Velazquez JR, et al. Clin Rev Allergy Immunol. 2011 Aug;41(1):76-88. doi: 10.1007/s12016-010-8202-6. Clin Rev Allergy Immunol. 2011. PMID: 20352527 Review. - Chemokine-enhanced chemotaxis of lymphangioleiomyomatosis cells with mutations in the tumor suppressor TSC2 gene.
Pacheco-Rodriguez G, Kumaki F, Steagall WK, Zhang Y, Ikeda Y, Lin JP, Billings EM, Moss J. Pacheco-Rodriguez G, et al. J Immunol. 2009 Feb 1;182(3):1270-7. doi: 10.4049/jimmunol.182.3.1270. J Immunol. 2009. PMID: 19155472 Free PMC article. - Neuronal chemokines: versatile messengers in central nervous system cell interaction.
de Haas AH, van Weering HR, de Jong EK, Boddeke HW, Biber KP. de Haas AH, et al. Mol Neurobiol. 2007 Oct;36(2):137-51. doi: 10.1007/s12035-007-0036-8. Epub 2007 Jul 10. Mol Neurobiol. 2007. PMID: 17952658 Free PMC article. Review. - G protein-coupled receptors and the modification of FcepsilonRI-mediated mast cell activation.
Kuehn HS, Gilfillan AM. Kuehn HS, et al. Immunol Lett. 2007 Nov 15;113(2):59-69. doi: 10.1016/j.imlet.2007.08.007. Epub 2007 Sep 18. Immunol Lett. 2007. PMID: 17919738 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical